IRM vs TERN · P/E 136, rev $6.15B vs $6.12B cap
Iron Mountain Incorporated (IRM) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the IRM and TERN stock pages for the full models.
Not investment advice.